FDA Clears Absorbable Hemostatic Bone Putty From Abyrx,™Inc.

Abyrx,™ Inc. Receives FDA 510(k) Clearance for New Absorbable Hemostatic Bone Putty (AHBP™) (via PR Newswire)

IRVINGTON, N.Y., June 12, 2013 /PRNewswire/ — Abyrx, Inc., a privately-held therapeutic device company, today announced that the United States Food and Drug Administration has cleared its new Absorbable Hemostatic Bone Putty (AHBP) for clinical use in the United States. AHBP is provided ready-to-…